Compelo Medical Devices is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More
Close
Dismiss

Arseus Q2 2009 Revenue Increases By 10.6%

Arseus NV (Arseus) has reported turnover of EUR100 million for the second quarter of 2009, up 10.6%, compared with the sales of EUR90.4 million in the year-ago quarter. It also reported turnover of EUR190.1 million for the first half of 2009, up 11.5%, compared with the turnover of EUR170.5 million in the year-ago period.

Ger van Jeveren, chief executive officer of Arseus: Despite the adverse economic conditions, all Arseus divisions contributed to the strong 10.6% total turnover growth and 6.9% organic growth in the second quarter of 2009. Thanks to our unique combination of activities in the health care sector, our leading market positions, our strong balance sheet, our flexible organisation and our dedicated staff, who are able to respond swiftly and effectively to the changing market conditions, the economic recession has had little impact on Arseus.

FAGRON

Fagron’s turnover was 9.6% higher in the second quarter of 2009 at EUR38.7 million, with organic growth of 5.7%. The greenfield operations in France and the UK sustained the vigorous growth achieved in previous quarters. With these excellent results, Fagron has further consolidated its European market leadership.

ARSEUS DENTAL

Arseus Dental’s turnover in the second quarter was up 10.9% at EUR41.6 million. Organic turnover growth was 6.3%, with above-average organic growth in Germany and France.

ARSEUS MEDICAL

Arseus Medical’s turnover grew 13.5% in the second quarter to EUR12.6 million, mainly thanks to the strong performance by the surgical and bandagiste divisions in Belgium and the completion of two large orders in the hospital and ophthalmology divisions that had been deferred from the first quarter.

CORILUS

Corilus turnover in the second quarter was 9.2% higher at EUR7.1 million. Organic growth was 5.7%. The Arseus executive committee has appointed Dirk Van Lerberghe as general manager of Corilus. His priority task will be rolling out the successful Corilus software applications in Europe. Cinnaber, the veterinary practice management system, will shortly be launched in France and the Netherlands following its success in Belgium.

Arseus is a multinational group of companies that provides products, services and concepts for professionals and institutions active in the healthcare sector in Europe.